Lymphoma p53 Hotspot Mutation Cell Panel (ATCC® TCP-2050™) Organism: Homo sapiens, human / General Information Documentation Print Email Share Share this product Facebook Twitter Google+ Permits and Restrictions View Permits Organism Homo sapiens, human Components EB-3, ATCC CCL-85 CA46, ATCC CRL-1648 Namalwa, ATCC CRL-1432 DB, ATCC CRL-2289 SUP-T1, ATCC CRL-1942 Applications Biological understanding of top genetic alterations in lymphoma Novel anti-cancer drug targeting Reactivation of mutant p53 Studies related to p53 molecular mechanisms Testing small molecules or biologics for cancer drug development Biosafety Level 2 [Cells contain herpes virus] Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. Comments The Lymphoma p53 Hotspot Mutation Cell Panel is comprised of five select suspension cell lines derived from lymphomas. Mutations have been sequenced and validated by ATCC. This panel includes a cell line with WT p53 as well as cell lines with p53 hotspot mutations at codons 248 and 273 Product Format 5 cryopreserved cell lines Storage Conditions liquid nitrogen vapor phase Permits These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment. Basic Documentation Product Sheet Certificate of Analysis SDS Other Documentation p53 Hotspot Mutation Data